29/07/2015 09:35:12 Free Membership Login

Inovio Pharmaceuticals, Inc. News (NASDAQ:INO)

DateTimeSource
Headline
05/27/20151:00AMGLOBEInovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinical Development
PLYMOUTH MEETING, Pa., May 27, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced it will advance its DNA vaccine for MERS (Middle East Respiratory Syndrome) into a phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science Inc. (KSE: 011000), an international DNA... More...>>
05/26/20158:00AMGLOBEInovio to Present at Jefferies Healthcare Conference
PLYMOUTH MEETING, Pa., May 26, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Dr. J. Joseph Kim, President and CEO, will give a corporate presentation at the Jefferies 2015 Healthcare Conference on Thursday, June 4 at 8:30 AM ET. A live and archived version of Dr. Kim's presentation... More...>>
05/18/20158:05AMTMF3 Types of Risks Facing Biotech Stocks
http://www.fool.com/investing/high-growth/2015/05/18/3-types-of-risks-facing-biotech-stocks.aspx?source=eptadnlnk0000002 More...>>
05/12/20155:00AMGLOBEInovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola
PLYMOUTH MEETING, Pa., May 12, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company has initiated a phase I trial to evaluate safety, tolerability and immune responses of Inovio's DNA immunotherapy for Ebola. In previously published preclinical testing, Inovio's DNA-based... More...>>
05/11/20157:00AMGLOBEInovio Pharmaceuticals Reports 2015 First Quarter Financial Results
PLYMOUTH MEETING, Pa., May 11, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today reported financial results for the quarter ended March 31, 2015. Total revenue was $5.2 million for the three months ended March 31, 2015, compared to $2.4 million for the same period in 2014. Total operating expenses... More...>>
05/05/201512:19PMGLOBEInovio Pharmaceuticals Closes $87.4 Million Underwritten Financing
PLYMOUTH MEETING, Pa., May 5, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) ("Inovio" or the "Company"), today closed its previously announced underwritten public offering of 10,925,000 shares of the Company's common stock, including 1,425,000 shares of common stock issued pursuant to the underwriter's... More...>>
05/01/20158:00AMGLOBEInovio Pharmaceuticals to Report First Quarter 2015 Financial Results May 11, 2015
PLYMOUTH MEETING, Pa., May 1, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that it will host a conference call and live webcast to report its 2015 first quarter financial results on Monday, May 11, 2015 at 8:30 a.m. ET. A live and archived version of the audio presentation will be... More...>>
04/30/201512:47PMTMFWhy Shares of Inovio Pharmaceuticals, Inc. Cratered Today
http://www.fool.com/investing/general/2015/04/30/why-shares-of-inovio-pharmaceuticals-inc-cratered.aspx?source=eptadnlnk0000002 More...>>
04/30/20159:00AMGLOBEInovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
PLYMOUTH MEETING, Pa., April 30, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) ("Inovio" or the "Company"), today announced the pricing of an underwritten public offering of 9,500,000 shares of common stock for a public offering price of $8.00 per share. The gross proceeds to Inovio from this offering... More...>>
04/29/20154:01PMGLOBEInovio Pharmaceuticals Announces Public Offering of Common Stock
PLYMOUTH MEETING, Pa., April 29, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & Co. and Stifel are acting as joint bookrunning managers for... More...>>
04/21/20153:00AMGLOBEInovio Pharmaceuticals and Roche Initiate Clinical Trial for Inovio's DNA Immunotherapy to Treat Chronic Hepatitis B Infectio...
PLYMOUTH MEETING, Pa., April 21, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that it has initiated a phase I trial to evaluate Inovio's DNA immunotherapy in patients who are chronically infected with hepatitis B. In 2013, Roche and Inovio entered into a partnership to co-develop and... More...>>
04/15/20158:59AMTMF3 Biotech Stocks That May Disappear Before 2020
http://www.fool.com/investing/general/2015/04/15/3-biotech-stocks-that-may-disappear-before-2020.aspx?source=eptadnlnk0000002 More...>>
04/09/201510:12AMGLOBEInovio Pharmaceuticals' HPV Immunotherapy Recognized as "Best Therapeutic Vaccine" by World Vaccine Congress
PLYMOUTH MEETING, Pa., April 9, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) today announced that it was recognized with a prestigious industry award at the World Vaccine Congress being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards honor outstanding vaccine advancements... More...>>
04/09/20158:00AMGLOBEInovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in Head & Neck Cancer Patients
PLYMOUTH MEETING, Pa., April 9, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients with head and neck cancer associated with human papillomavirus (HPV) types... More...>>
04/08/20156:00AMGLOBEInovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent a...
PLYMOUTH MEETING, Pa., April 8, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that the company has been selected to receive a grant from the Defense Advanced Research Projects Agency (DARPA) to lead a collaborative team to develop multiple treatment and prevention approaches against... More...>>
04/04/20159:59AMTMFHas the Biotech Bubble Already Popped?
http://www.fool.com/investing/general/2015/04/04/has-the-biotech-bubble-already-popped.aspx?source=eptadnlnk0000002 More...>>
04/03/20158:04AMTMF5 Promising Biotech Stocks Under $10
http://www.fool.com/investing/small-cap/2015/04/03/5-promising-biotech-stocks-under-10.aspx?source=eptadnlnk0000002 More...>>
03/19/20158:00AMGLOBEInovio Pharmaceuticals to Present at Alliance Regenerative Medicine's 2015 Regen Med Investor Day
PLYMOUTH MEETING, Pa., March 19, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Chief Operating Officer, Dr. Niranjan Sardesai, will present at the 3rd Annual Regen Med Investor Day to be held Wednesday, March 25, 2015 at the Metropolitan Club in New York City. Dr. Sardesai's presentation... More...>>
03/18/20158:00AMGLOBEInovio Pharmaceuticals Appoints Scott M. White, M.D. Vice President, Clinical Development -- Infectious Diseases
PLYMOUTH MEETING, Pa., March 18, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today the appointment of Scott M. White, M.D. as Vice President, Clinical Development – Infectious Diseases. Dr. White will be responsible for advancing Inovio's infectious disease portfolio of DNA immunotherapies... More...>>
03/16/20152:10PMTMFWhy Inovio Pharmaceuticals Inc. Shot Higher Today
http://www.fool.com/investing/general/2015/03/16/why-inovio-pharmaceuticals-shot-higher-today.aspx?source=eptadnlnk0000002 More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ino150729 09:35